54.93 USD
▼-2.69-4.67%
盘后 54.48 -0.82%
2026-09-15
市值
$1.61B
市盈率
131.66
EPS
0.43
股息率
—
52 周区间
14.27 – 66.37
成交量
543.87K
Beta
0.90
目标价
71.00
52W 低 14.2752W 高 66.37
价格走势
公司简介
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing vari...